BINDYABEN PATEL: Open Payments
NPI 1912484213 · PORTSMOUTH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,593 in 92 payments from 16 companies in 2025. Trend: 2023 $696 · 2024 $1,713 · 2025 $1,593
Food & beverage: $1,593
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $370 |
| Novo Nordisk Inc | 18 | $247 |
| Lilly USA, LLC | 16 | $205 |
| ABBVIE INC. | 9 | $155 |
| Amgen Inc. | 9 | $141 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $94 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
| Exact Sciences Corporation | 3 | $48 |
| Collegium Pharmaceutical, Inc. | 3 | $47 |
Products named: AIRSUPRA, MOUNJARO, BREZTRI, JARDIANCE, OTEZLA, Wegovy, VRAYLAR, Kerendia.
Industry payments across OH — which companies pay providers there.
